Effects of a low-fat, high-fiber diet and exercise program on breast cancer risk factors in vivo and tumor cell growth and apoptosis in vitro

Nutrition and Cancer

Volumn 55, Issue 1, 2006, Pages 28-34

  Barnard, R James ^a   Gonzalez, Jenny Hong ^a   Liva, Maud E ^a   Ngo, Tung H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR; INSULIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN C;

ADULT; AGED; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER RISK; CELL STRAIN MCF 7; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; EXERCISE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN BLOOD LEVEL; LIPID DIET; LOW FAT DIET; OBESITY; POSTMENOPAUSE; RISK FACTOR; RISK REDUCTION; TUMOR GROWTH;

AGED; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; CELL LINE, TUMOR; DIET, FAT-RESTRICTED; DIETARY FATS; DIETARY FIBER; ESTRADIOL; ESTROGENS; EXERCISE; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; OBESITY; POSTMENOPAUSE; RISK FACTORS;

EID: 33749164990     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1207/s15327914nc5501_4     Document Type: Article

References (51)

1. American Cancer Society: Cancer Facts and Figures. Atlanta, GA: American Cancer Society, 2005.
2. Greenlee RT, Murray T, Bolden S, and Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 50, 7-33, 2000.
3. Pike MC, Spicer DV, Dahmoush L, and Press MF: Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15, 17-35, 1993.
4. Hankinson SE, Colditz GA, and Willett WC: Towards an integrated model for breast cancer etiology: the lifelong interplay of genes, lifestyle, and hormones. Breast Cancer Res 6, 213-218, 2004.
5. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, et al.: Migration patterns and breast cancer risk in Asian-American women. JNCI 85, 1819-1827, 1993.
6. Ursin G, Bernstein L, and Pike MC: Breast cancer. Cancer Surv 19-20, 241-264, 1994.
7. Harvie M, Hooper L, and Howell AH: Central obesity and breast cancer risk: a systematic review. Obes Rev 4, 157-173, 2003.
8. Rose DP, Komninou D, and Stephenson GD: Obesity, adipocytokines, and insulin resistance in breast cancer. Obes Rev 5, 153-165, 2004.
9. Wolf I, Sadetzki S, Catane R, Karasik A, and Kaufman B: Diabetes mellitus and breast cancer. Lancet Oncol 6, 103-111, 2005.
10. Malin A, Dai Q, Yu H, Shu XO, Jin F, et al.: Evaluation of the synergistic effect of insulin resistance and insulin-like growth factors on the risk of breast carcinoma. Cancer 100, 694-700, 2004.
11. Dumitrescu RG and Cotarla I: Understanding breast cancer risk - where do we stand in 2005? J Cell Mol Med 9, 208-221, 2005.
12. Thune I and Furberg AS: Physical activity and cancer risk: dose-response and cancer, all sites and site-specific. Med Sci Sports Exerc 33 (suppl 6), S530-S550, 2001.
13. Wegge JK, Roberts CK, Ngo TH, and Barnard RJ: Effect of diet and exercise intervention on inflammatory and adhesion molecules in postmenopausal women on hormone replacement therapy and at risk for coronary artery disease. Metabolism 53, 377-381, 2004.
14. Lansang MC, Williams GH, and Carroll JS: Correlation between the glucose clamp technique and the homeostasis model assessment in hypertension. Am J Hypertens 14, 51-53, 2001.
15. Stephenson GD and Rose DP: Breast cancer and obesity: an update. Nutr Cancer 45, 1-16, 2003.
16. Keinan-Boker L, Bueno De Mesquita HB, Kaaks R, Van Gils CH, Van Noord PA, et al.: Circulating levels of insulin-like growth factor I, its binding proteins-1,-2, -3, C-peptide and risk of postmenopausal breast cancer. Int J Cancer 106, 90-95, 2003.
17. McTernan PG, Anwar A, Eggo MC, Barnett AH, Stewart PM, et al.: Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue. Int J Obes Relat Metab Disord 24, 875-881, 2000.
18. Goldin BR, Adlercreutz H, Gorbach SL, Warram JH, Dwyer JT, et al.: Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med 307, 1542-1547, 1982.
19. Howe GR, Hirohata T, Hislop TG, Iscovich JM, Yuan JM, et al.: Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. JNCI 8, 561-569, 1990.
20. Heber D, Ashley JM, Leaf DA, and Barnard RJ: Reduction of serum estradiol in postmenopausal women given free access to low-fat high-carbohydrate diet. Nutrition 7, 137-139, 1991.
21. Bagga D, Ashley JM, Geffrey SP, Wang HJ, Barnard RJ, et al.: Effects of a very low fat, high fiber diet on serum hormones and menstrual function. Implications for breast cancer prevention. Cancer 76, 2491-2496, 1995.
22. Prentice R, Thompson D, Clifford C, Gorbach S, Goldin B, et al.: Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group. JNCI 82, 129-134, 1990.
23. Rose DP, Boyar AP, Cohen C, and Strong LE: Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins. JNCI 78, 623-626, 1987.
24. Woods MN, Gorbach SL, Longcope C, Goldin BR, Dwyer JT, et al.: Low-fat, high-fiber diet and serum estrone sulfate in premenopausal women. Am J Clin Nutr 49, 1179-1183, 1989.
25. Staren ED and Omer S: Hormone replacement therapy in postmenopausal women. Am J Surg 188, 136-149, 2004.
26. Humphries KH and Gill S: Risks and benefits of hormone replacement therapy: the evidence speaks. CMAJ 168, 1001-1010, 2003.
27. Freedman LS, Clifford C, and Messina M: Analysis of dietary fat, calories, body weight, and the development of mammary tumors in rats and mice: a review. Cancer Res 50, 5710-5719, 1990.
28. Armstrong B and Doll R: Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 15, 617-631, 1975.
29. Hunter DJ, Spiegelman D, Adami HO, Beeson L, van den Brandt PA, et al.: Cohort studies of fat intake and the risk of breast cancer - a pooled analysis. N Engl J Med 334, 356-361, 1996.
30. Tymchuk CN, Tessler SB, and Barnard RJ: Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise. Nutr Cancer 38, 158-162, 2000.
31. Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, et al.: Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20, 42-51, 2002.
32. Muti P, Quattrin T, Grant BJ, Krogh V, Micheli A, et al.: Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 11, 1361-1368, 2002.
33. Goodyear LJ and Kahn BB: Exercise, glucose transport, and insulin sensitivity. Annu Rev Med 49, 235-261, 1998.
34. Lai A, Sarcevic B, Prall OW, and Sutherland RL: Insulin/insulin-like growth factor-I and estrogen cooperate to stimulate cyclin E-Cdk2 activation and cell cycle progression in MCF-7 breast cancer cells through differential regulation of cyclin E and p21(WAF1/Cip1). J Biol Chem 276, 25823-25833, 2001.
35. Plymate SR, Hoop RC, Jones RE, and Matej LA: Regulation of sex hormone-binding globulin production by growth factors. Metabolism 39, 967-970, 1990.
36. Thissen JP, Ketelslegers JM, and Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocr Rev 15, 80-101, 1994.
37. LeRoith D and Roberts CT Jr: The insulin-like growth factor system and cancer. Cancer Lett 195, 127-137, 2003.
38. Fletcher O, Gibson L, Johnson N, Altmann DR, Holly JM, et al.: Polymorphisms and circulating levels in the insulin-like growth factor system and risk of breast cancer: a systematic review. Cancer Epidemiol Biomarkers Prev 14, 2-19, 2005.
39. Dupont J and Le Roith D: Insulin-like growth factor 1 and oestradiol promote cell proliferation of MCF-7 breast cancer cells: new insights into their synergistic effects. Mol Pathol 54, 149-154, 2001.
40. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, et al.: Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 13, 787-796, 1999.
41. Sachdev D and Yee D: The IGF system and breast cancer. Endocr Relat Cancer 8, 197-209, 2001.
42. Zhang X and Yee D: Insulin-like growth factor binding protein-1 (IGFBP-1) inhibits breast cancer cell motility. Cancer Res 62, 4369-4375, 2002.
43. Holmes MD, Chen WY, Feskanich D, Kroenke CH, and Colditz GA: Physical activity and survival after breast cancer diagnosis. JAMA 293, 2479-2486, 2005.
44. Jain M, Miller AB, and To T: Premorbid diet and the prognosis of women with breast cancer. JNCI 86, 1390-1397, 1994.
45. Ngo TH, Barnard RJ, Tymchuk CN, Cohen P, and Aronson WJ: Effect of diet and exercise on serum insulin, IGF-I, and IGFBP-1 levels and growth of LNCaP cells in vitro (United States). Cancer Causes Control 13, 929-935, 2002.
46. Arteaga CL and Osborne CK: Growth inhibition of human breast cancer cells in vitro with an antibody against the type I somatomedin receptor. Cancer Res 49, 6237-6241, 1989.
47. Milazzo G, Giorgino F, Damante G, Sung C, Stampfer MR, et al.: Insulin receptor expression and function in human breast cancer cell lines. Cancer Res 52, 3924-3930, 1992.
48. Forman MR, Hursting SD, Umar A, and Barrett JC: Nutrition and cancer prevention: a multidisciplinary perspective on human trials. Annu Rev Nutr 24, 223-254, 2004.
49. Rock CL, Flatt SW, Thomson CA, Stefanick ML, Newman VA, et al.: Effects of a high-fiber, low-fat diet intervention on serum concentrations of reproductive steroid hormones in women with a history of breast cancer. J Clin Oncol 22, 2379-2387, 2004.
50. Leung PS, Aronson WJ, Ngo TH, Golding LA, and Barnard RJ: Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro. J Appl Physiol 96, 450-454, 2004.
51. Malin A, Matthews CE, Shu XO, Cai H, Dai Q, et al.: Energy balance and breast cancer risk. Cancer Epidemiol Biomarkers Prev 14, 1496-1501, 2005.